When Joe Biden launched the Cancer Moonshot initiative in 2016 as vice president, he traveled to cancer centers across the country to promote the initiative’s goal of accelerating progress toward a cure. The tour included a visit to Huntsman Cancer Institute, where he met with experts to discuss strategies for advancing scientific breakthroughs and improving patient care.
Six years later, as president, Biden announced a relaunch of the Cancer Moonshot initiative at an event on February 2, 2022. He introduced new goals of decreasing cancer mortality by 50% in the next 25 years and improving the lives of people affected by cancer. Huntsman Cancer Institute’s Phyllis Pettit Nassi, MSW, was among the small group of attendees, which included colleagues from cancer centers and members of Congress.
"To be present for this announcement was very exciting," says Nassi, who believes her policy work in Washington is likely what garnered an invitation. Though the White House event was her first COVID-era visit to the city, she has continued to meet—virtually—with Washington policymakers during the pandemic.
"I’m currently working on three initiatives with the National Academies, making sure the voice of the American Indian and rural and frontier populations are included," she says.
Through her work with the American Indian Program at Huntsman Cancer Institute, she advocates for the cancer needs of tribal members in the Mountain West. This demographic group experiences cancer disparities, the occurrence of worse health outcomes due to economic, social, cultural, environmental, and geographic disadvantages. Part of the Cancer Moonshot is aimed at addressing disparities.
"We know cancer as a disease for which there are stark inequities in access to cancer screening, diagnostics, and treatment across race, gender, region, and resources," says a White House statement about the Moonshot. "We can ensure that every community in America—rural, urban, Tribal, and everywhere else—has access to cutting-edge cancer diagnostics, therapeutics, and clinical trials."
Much of Nassi’s work addresses these issues. She travels to tribal nations to provide education about cancer risk and prevention, with the goal of helping reduce cancer incidence in these populations through preventable measures. She supports patients both while they receive treatment at Huntsman Cancer Institute and after they return home, helping them access follow-up care and basic necessities.
"We help make sure they’re getting food and other supplies," she says. "We work with their providers back home, help them with housing and gas. We had one patient who enrolled in a clinical trial and needed to live [near Huntsman Cancer Institute] for a while, so we made sure she had the resources to stay. We just touch base with everyone and let them know we’re here."
Nassi hopes to work on Cancer Moonshot disparities initiatives with colleagues she met at the White House. The event inspired a spirit of collaboration, she says.
"It was wonderful to see the commitment to the project and to serving people with cancer."
Media Contact
Heather Simonsen
Public Affairs Senior Manager
Huntsman Cancer Institute
801 581-3194
public.affairs@hci.utah.edu
About Huntsman Cancer Institute at the University of Utah
Huntsman Cancer Institute at the University of Utah is the National Cancer Institute-designated Comprehensive Cancer Center for Utah, Idaho, Montana, Nevada, and Wyoming. With a legacy of innovative cancer research, groundbreaking discoveries, and world-class patient care, we are transforming the way cancer is understood, prevented, diagnosed, treated, and survived. Huntsman Cancer Institute focuses on delivering the most advanced cancer healing and prevention through scientific breakthroughs and cutting-edge technology to advance cancer treatments of the future beyond the standard of care today. We have more than 300 open clinical trials and 250 research teams studying cancer. More genes for inherited cancers have been discovered at Huntsman Cancer Institute than at any other cancer center. Our scientists are world-renowned for understanding how cancer begins and using that knowledge to develop innovative approaches to treat each patient’s unique disease. Huntsman Cancer Institute was founded by Jon M. and Karen Huntsman.